SSR MINING INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data SSR MINING INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	491	449	421	607	853	1,474	1,148	1,427	996	1,630
Cost of revenue	337	336	344	350	445	671	608	804	514	653
Gross profit	154	113	76.8	171	309	803	540	623	482	976
Selling, general and administrative	22.1	20.3	32.9	18.1	24.6
General and administrative				31.1	33.6	56.6	71.7	67.5	62.9	108
Operating income	113	101	29.9	118	188	444	190	-130	-322	461
Interest expense	26	34.9	33.6	12.8	13.9	19.1	19.1	16.6	13	14.6
Interest income	1.77	6.13	11.8	11.9	6.55
Other non-operating income				18.3	13.5	-29.6	50.6	-72.2	3.55	-18.3
Pre-tax income	81	74.6	8.09	137	202	415	241	-202	-319	443
Income tax	16	3.12	8.12	35.4	43.2	-14.1	30.1	-82.5	33.3	80.2
Income from continuing operations	154	113	76.8	171	309
Net income to minority interests	0	2.15	-6.41	-1.56	5.63	57.8	16.3	-22.2	-91.3	-33.3
Net income	65	69.3	6.38	103	152	368	194	-98	-261	396
EBITDA	113	102	30.1	204	298	672	372	83.8	-192	578
EPS, basic	1.05	0.96	0.08	0.84	1.00	1.70	0.92	-0.48	-1.29	1.95
EPS, diluted	1.03	0.95	0.08	0.78	0.96	1.63	0.89	-0.48	-1.29	1.85
Shares, basic (weighted)								205	202	203
Shares, diluted (weighted)				135	164	228	222	205	202	217

Balance sheet

	FY2017	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	327	460	421	504	861	1,018	655	492	388	516
Short-term investments					26.7	40.4	40.3	20.9	29.5	40.8
Receivables	58.4	38.1	42.8	71.8	38.5	86.1	62.6	91.3	84.2	94
Inventory	155	183	233	238	437	389	502	515	464	489
Other current assets					16.2	31.5	27.8	25.8	23.2	23.1
Total current assets	704	800	733	900	1,424	1,600	1,376	1,196	1,029	1,287
Property, plant and equipment	664	659	701	769	3,470	3,250	3,549	3,873
Lease right-of-use assets			0	3.5	9.36	7.53	17.9	21	18.5	16.9
Goodwill	49.8	49.8	49.8	49.8	49.8	49.8	49.8	0
Long-term investments							4.56	7.41	5.17	0
Other non-current assets					40.7	41.2	57.7	74.2	78.3	57.8
Total assets	1,439	1,537	1,521	1,692	5,177	5,211	5,255	5,386	5,189	6,094
Accounts payable	61.5	60.2	78.5		42.9	34.8	78.9	37.1	30.5	25.4
Accrued liabilities					44.5	51.5	68.3	66.5	71.8	82
Short-term debt			0	114	71	71.5	71.8	0.92	11	230
Total current liabilities	144	71.5	83.3	234	249	284	279	171	219	618
Long-term debt					367	295	227	228		51.4
Lease liabilities			0	3.35	7.53	5.53	17	21	19.3	17.4
Other non-current liabilities					25.7	12.1	23.9	56.5	26	39.3
Total liabilities	537	514	515	616	1,327	1,159	1,128	1,082	1,242	1,780
Total debt	223	236	248	284	438	367	298	228	229	281
Retained earnings	-209	-140	-133	-76	92.1	398	522	368	113	509
Shareholders' equity	902	1,001	974	1,134	3,335	3,538	3,580	3,373	3,107	3,508
Minority interests	0	23	31.8	0	512	515	546	931	840	806
Total equity	902	1,024	943	1,043	3,847	4,053	4,126	4,304	3,947	4,314
Total liabilities and equity	1,439	1,537	1,521	1,750	5,177	5,211	5,255	5,386	5,189	6,094
Shares outstanding					220	212	207	203	202	203

Cash flow statement

	FY2017	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	65	71.5	-0.03	101	157	426	210	-120	-353	362
Depreciation and amortization	0.26	0.2	0.19	85.6	109	228	181	214	130	116
Stock-based compensation				14.4	15.9	14.8	6.47	5.17	4.72	44.6
Deferred income tax				10.6	20.7	-131	-67.9	-136	-21.9	-56.7
Change in inventory				-11.4	-21.7	-20.8	-108	-33.3	-80.3	-148
Change in payables				16.7	7.76	-6.88	40.8	-41.9	-6.49	-1.05
Cash from operations	171	145	59.8	118	307	609	161	422	40.1	472
Capital expenditures	-42.3	-28.9	-158	-111	-139	-165	-138	-223	-144	-230
Acquisitions							-170	-120	0	-106
Purchases of investments				-3.44	-29.6	-10.1	-9	-15.5	-31.3	-102
Sales and maturities of investments				3.31	97.1	11.4	35.6	19.7	27.3	97.4
Cash from investing	-43.3	-15.5	-116	-115	240	-129	-236	-339	-143	-340
Debt issued			0	0	3.09	0	0
Debt repaid	-3.85	0		0	-35	-70	-71.2	-71.2	-0.92	0
Stock issued				7.88	6.55	8.78	2.63	0.21	0
Share buybacks				0	0	-148	-100	-56.3	-9.83	0
Dividends paid				0	0	-43.2	-58.8	-57.7	0	0
Cash from financing	-11.1	4.6	20.5	81.5	-158	-320	-272	-182	6.92	26.2
Exchange rate effect	-1.09	-1.1	-5.01	0.01	0.79	-3.14	-16.6	-96.8	-8.54	-11.4
Net change in cash	115	133	-40.7	84.7	390	157	-364	-197	-105	147
Free cash flow	128	116	-98.3	7.52	168	444	23.4	198	-103	242
Interest paid	8.09	15.2	13.8	11.6	13.6	12.5	22.6	16.5	7.43	9.04
Income taxes paid	18.6	4.3	12.8	20.9	43.7	58	146	33.6	25.5	101

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $33.84 on September 28, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	62.6%	Gross profit / revenue.
Operating margin	35.1%	Operating income / revenue.
EBITDA margin	41.3%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	40.0%	Pre-tax income / revenue.
Net margin	12.3%	Net income / revenue.
FCF margin	18.2%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	30.9%	Cash from operations / revenue.
Effective tax rate	20.5%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	7.0%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	5.6%	Net income / average total assets.
Return on invested capital (ROIC)	33.5%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue	3.1%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	12.7%	Capital expenditures / revenue.
D&A / revenue	6.2%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	63.7%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	12.4%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	13.8%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	102.7%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	21.8%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	25.9%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income CAGR, 3y	34.4%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	19.6%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA CAGR, 3y	15.8%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	14.2%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income CAGR, 3y	26.8%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	21.2%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS CAGR, 3y	27.6%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	14.0%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	1,076.0%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	43.1%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	9.0%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow CAGR, 3y	117.8%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	7.5%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	12.9%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-0.7%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	1.0%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	17.4%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	5.1%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	3.3%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	7.3%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-0.8%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	5.8%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	9.79x	Current assets / current liabilities.
Quick ratio	7.45x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	7.27x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.00x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	0.0%	Total debt / total assets.
Liabilities / assets	20.7%	Total liabilities / total assets.
Net debt	-$1.83B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	-2.29x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	77.6x	Operating income / interest expense.
Working capital	$2.22B	Current assets - current liabilities.
Tangible book value	$3.39B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.45x	Revenue / average total assets.
Inventory turnover	1.42x	Cost of revenue / average inventory.
Days inventory	258 days	365 x average inventory / cost of revenue.
Receivables turnover	41.8x	Revenue / average receivables.
Days sales outstanding	9 days	365 x average receivables / revenue.
Days payables	17 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	250 days	Days inventory + days sales outstanding - days payables.
FCF conversion	148.0%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	41.0%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$1.14	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$9.24	Revenue / diluted weighted shares.
FCF per share	$1.68	Free cash flow / diluted weighted shares.
Operating cash flow per share	$2.85	Cash from operations / diluted weighted shares.
Book value per share	$16.43	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$16.43	Tangible book value / shares outstanding.
Cash per share	$8.89	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$6.90B	Share price x shares outstanding.
Enterprise value	$5.07B	Market cap + total debt - cash - short-term investments.
P/E	29.0x	Market cap / net income. Only when net income is positive.
P/S	3.57x	Market cap / revenue.
P/B	2.03x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	2.03x	Market cap / tangible book value, when positive.
P/FCF	19.6x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	11.6x	Market cap / cash from operations, when positive.
EV/Sales	2.62x	Enterprise value / revenue.
EV/EBIT	7.47x	Enterprise value / operating income, when both are positive.
EV/EBITDA	6.34x	Enterprise value / EBITDA, when both are positive.
EV/FCF	14.4x	Enterprise value / free cash flow, when both are positive.
FCF yield	5.1%	Free cash flow / market cap.
Earnings yield	3.4%	Net income / market cap (the inverse of P/E).
PEG	1.05x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was SSR MINING INC.'s revenue in fiscal 2025?

SSR MINING INC. reported revenue of $1.63B for fiscal 2025, 63.7% higher than the year before.

Was SSR MINING INC. profitable in fiscal 2025?

Yes. Net income was $395.8M, a net margin of 24.3%.

How much free cash flow did SSR MINING INC. generate in fiscal 2025?

Cash from operations of $471.9M minus capital expenditures of $230.2M left free cash flow of $241.6M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to SSR MINING INC.